Therefore, further understanding the aspects of JAML-mediated efferocytosis will shed light on the key pathophysiological processes in AKI and provide novel therapeutic strategies for diseases driven by defective efferocytosis and impaired inflammation resolution. Here, JAML is linked to acute kidney injury.